Literature DB >> 24851811

Systems analysis of West Nile virus infection.

Mehul S Suthar1, Bali Pulendran2.   

Abstract

Emerging and re-emerging mosquito-borne viruses continue to pose a significant threat to human health throughout the world. Over the past decade, West Nile virus (WNV), Dengue virus (DENV), and Chikungunya virus (CHIKV), have caused annual epidemics of virus-induced encephalitis, hemorrhagic fever\shock syndromes, and arthritis, respectively. Currently, no specific antiviral therapies or vaccines exist for use in humans to combat or prevent these viral infections. Thus, there is a pressing need to define the virus-host interactions that govern immunity and infection outcome. Recent technological breakthroughs in 'omics' resources and high-throughput based assays are beginning to accelerate antiviral drug discovery and improve on current strategies for vaccine design. In this review, we highlight studies with WNV and discuss how traditional and systems biological approaches are being used to rapidly identify novel host targets for therapeutic intervention and develop a deeper conceptual understanding of the host response to virus infection.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24851811      PMCID: PMC4104408          DOI: 10.1016/j.coviro.2014.04.010

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  50 in total

1.  Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.

Authors:  Dong Jiang; Jessica M Weidner; Min Qing; Xiao-Ben Pan; Haitao Guo; Chunxiao Xu; Xianchao Zhang; Alex Birk; Jinhong Chang; Pei-Yong Shi; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV.

Authors:  Staci A Fischer
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

3.  Systems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme A delta isomerase, required for hepatitis C virus replication and likely pathogenesis.

Authors:  Angela L Rasmussen; Deborah L Diamond; Jason E McDermott; Xiaoli Gao; Thomas O Metz; Melissa M Matzke; Victoria S Carter; Sarah E Belisle; Marcus J Korth; Katrina M Waters; Richard D Smith; Michael G Katze
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

4.  Identification of a specific gene expression pattern associated with HCV-induced pathogenesis in HCV- and HCV/HIV-infected individuals.

Authors:  Kathie-Anne Walters; Maria W Smith; Sampa Pal; Jill C Thompson; Matthew J Thomas; Matthew M Yeh; David L Thomas; Matthew Fitzgibbon; Sean Proll; Nelson Fausto; David R Gretch; Robert L Carithers; Margaret C Shuhart; Michael G Katze
Journal:  Virology       Date:  2006-03-30       Impact factor: 3.616

5.  The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection.

Authors:  John S Errett; Mehul S Suthar; Aimee McMillan; Michael S Diamond; Michael Gale
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

6.  Pattern recognition receptor MDA5 modulates CD8+ T cell-dependent clearance of West Nile virus from the central nervous system.

Authors:  Helen M Lazear; Amelia K Pinto; Hilario J Ramos; Sarah C Vick; Bimmi Shrestha; Mehul S Suthar; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

7.  Tregs control the development of symptomatic West Nile virus infection in humans and mice.

Authors:  Marion C Lanteri; Katie M O'Brien; Whitney E Purtha; Mark J Cameron; Jennifer M Lund; Rachel E Owen; John W Heitman; Brian Custer; Dale F Hirschkorn; Leslie H Tobler; Nancy Kiely; Harry E Prince; Lishomwa C Ndhlovu; Douglas F Nixon; Hany T Kamel; David J Kelvin; Michael P Busch; Alexander Y Rudensky; Michael S Diamond; Philip J Norris
Journal:  J Clin Invest       Date:  2009-10-12       Impact factor: 14.808

8.  A paradoxical role for neutrophils in the pathogenesis of West Nile virus.

Authors:  Fengwei Bai; Kok-Fai Kong; Jianfeng Dai; Feng Qian; Lin Zhang; Charles R Brown; Erol Fikrig; Ruth R Montgomery
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

9.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

10.  Systems biology of vaccination for seasonal influenza in humans.

Authors:  Helder I Nakaya; Jens Wrammert; Eva K Lee; Luigi Racioppi; Stephanie Marie-Kunze; W Nicholas Haining; Anthony R Means; Sudhir P Kasturi; Nooruddin Khan; Gui-Mei Li; Megan McCausland; Vibhu Kanchan; Kenneth E Kokko; Shuzhao Li; Rivka Elbein; Aneesh K Mehta; Alan Aderem; Kanta Subbarao; Rafi Ahmed; Bali Pulendran
Journal:  Nat Immunol       Date:  2011-07-10       Impact factor: 25.606

View more
  7 in total

Review 1.  Pathogen manipulation of B cells: the best defence is a good offence.

Authors:  Katharina Nothelfer; Philippe J Sansonetti; Armelle Phalipon
Journal:  Nat Rev Microbiol       Date:  2015-02-09       Impact factor: 60.633

Review 2.  Risk factors for West Nile virus infection and disease in populations and individuals.

Authors:  Ruth R Montgomery; Kristy O Murray
Journal:  Expert Rev Anti Infect Ther       Date:  2015-01-30       Impact factor: 5.091

Review 3.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 4.  New insights into innate immune restriction of West Nile virus infection.

Authors:  Helen M Lazear; Michael S Diamond
Journal:  Curr Opin Virol       Date:  2014-12-31       Impact factor: 7.090

5.  Protection of mice deficient in mature B cells from West Nile virus infection by passive and active immunization.

Authors:  Daniela Giordano; Kevin E Draves; Lucy B Young; Kelsey Roe; Marianne A Bryan; Christiane Dresch; Justin M Richner; Michael S Diamond; Michael Gale; Edward A Clark
Journal:  PLoS Pathog       Date:  2017-11-27       Impact factor: 6.823

6.  West Nile Virus Seroprevalence, Connecticut, USA, 2000-2014.

Authors:  Megan E Cahill; Yi Yao; David Nock; Philip M Armstrong; Theodore G Andreadis; Maria A Diuk-Wasser; Ruth R Montgomery
Journal:  Emerg Infect Dis       Date:  2017-04       Impact factor: 6.883

Review 7.  Systems biology: A tool for charting the antiviral landscape.

Authors:  James R Bowen; Martin T Ferris; Mehul S Suthar
Journal:  Virus Res       Date:  2016-01-12       Impact factor: 3.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.